Keck School of Medicine of USC

 Alzheimer’s Therapeutic Research Institute

USC ATRI holds second annual Partnership Meeting

February 6th, 2017|

The USC Alzheimer’s Therapeutic Research Institute (USC ATRI) held its second annual Partnership Meeting in San Diego recently.

The meeting, which was attended by 125 clinical trial protocol

Neurologist Paul Aisen works to stop Alzheimer’s before it starts

December 21st, 2016|

The researcher explains five things to know about the only disease among the top 10 in America that cannot be prevented, cured or slowed
Scientists at the Alzheimer’s Therapeutic

Keck faculty among the world’s most influential researchers

December 16th, 2016|

Sir Isaac Newton once referred to the process of discovery as “standing on the shoulders of giants,” meaning that revolutionary science and innovation is built on the

New Alzheimer’s study aims to delay or prevent symptoms

June 21st, 2016|

The international trial co-managed by USC will test a drug in people who show no symptoms of the disease

USC researchers announced Tuesday they will test a promising drug

USC Alzheimer’s Therapeutic Research Institute hosts leading neuroscientists for two-day meeting

February 24th, 2016|

Top researchers from across the U.S. gathered in San Diego recently to commemorate a renewed commitment to understand and fight the leading fatal neurodegenerative disease affecting the

Advancing Alzheimer’s treatment options through collaboration

November 9th, 2015|

Paul Aisen, MD, the founding director of the USC Alzheimer’s Therapeutic Research Institute, is the newest member of the Keck School of Medicine of USC whose focus